发明名称 |
PHARMACEUTICAL COMPOSITIONS |
摘要 |
<p>The invention relates to an oral solid pharmaceutical composition comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof and at least one pharmaceutically acceptable excipient and which is, on average, at least 1.2 times more bioavailable than a valsartan capsule. [no suitable figure selected for publication]</p> |
申请公布号 |
SG162605(A1) |
申请公布日期 |
2010.07.29 |
申请号 |
SG20050017827 |
申请日期 |
2001.06.20 |
申请人 |
NOVARTIS AG |
发明人 |
GANTER, SABINA, MARIA;WAGNER, ROBERT, FRANK |
分类号 |
A61K9/16;A61K9/20;A61K31/41;A61P9/04;A61P9/12;A61P43/00;(IPC1-7):A61K31/41;A61P7/10 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|